Qualitative Assessment of the Impact of TTNS on QOL and Participation
This study through the use of semi-structured interviews or focus groups will explore the lived experience with Transcutaneous Tibial Nerve Stimulation (TTNS) with Neurogenic Lower Urinary Tract Dysfunction to generate user-defined themes regarding bladder function and catheter-related barriers and the daily impacts on one's life.
Conditions:
🦠 Neurogenic Bladder 🦠 Urinary Retention 🦠 Urinary Tract Infections 🦠 Spinal Cord Injuries
🗓️ Study Start (Actual) 31 May 2022
🗓️ Primary Completion (Estimated) October 2024
✅ Study Completion (Estimated) October 2024
👥 Enrollment (Estimated) 20
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Washington, District of Columbia, United States

📋 Eligibility Criteria

Description

  • Inclusion:
  • Participated in TTNS Study for 1 year.
Ages Eligible for Study: 18 Years to 75 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 27 January 2020
  • First Submitted that Met QC Criteria 28 January 2020
  • First Posted 30 January 2020

Study Record Updates

  • Last Update Submitted that Met QC Criteria 5 September 2023
  • Last Update Posted 6 September 2023
  • Last Verified September 2023